CATALYSTReuters • 2h ago
Indian shares set for positive start on talks to end Iran war, strong Reliance earnings - ReutersIndian shares set for positive start on talks to end Iran war, strong Reliance earnings Reuters
Why CNXU Stock slipped -1.74% Today — RQD Quant Desk Flash
$2.83 -1.74% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot)
EXT / AFTER-HRS: $2.82
Conexeu Sciences Inc. (CNXU) carries a Roarable Rating of D+ (Sell) with 56/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.
ROARABLE D+ • SELL / AVOID
Cap $85.8M
⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER
Click Any Pre-Computed AI Quant Specialist Briefing on CNXU Below — or Connect Your Own ChatGPT / Claude
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief)
Is CNXU stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼
As of 2026-11-01, Conexeu Sciences Inc. (NASDAQ: CNXU) is rated D+ (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 56/100 at a spot price of $2.83 (-1.74% 1D, market cap $85.8M). Pillar breakdown: Fundamental Cash Engine 10/20, Institutional 13F & Options Flow 9/20, Executive Insider Alignment 13/20, FRED Macro Regime Fit 15/20, and SEC Balance-Sheet Forensics 9/20. Across 1016 tracked Health Care issuers, CNXU ranks #269 in composite RQD confidence.
✓ Pre-computed one-to-many AI Quant brief
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief)
How does CNXU compare to LAKE and NTRB in the Health Care sector?
▼
Within the Health Care sector (Industrial Specialties), CNXU carries a Roarable D+ (56/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of —. By comparison, LAKE (Lakeland Industries Inc.) holds a D- grade (38/100 RQD, P/E N/A, ROIC -9.5%, cap $88.2M) and NTRB (Nutriband Inc.) posts a D- grade (40/100 RQD, P/E N/A, ROIC -35.0%, cap $80.7M). Among the 5-stock peer group, APT leads on earnings multiple (16.2x) while APT leads on capital efficiency (6.7% ROIC).
✓ Pre-computed one-to-many AI Quant brief
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief)
What are the biggest fundamental strengths and SEC risk factors for CNXU?
▼
Per CNXU's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-10-31, CIK 0002066836), Conexeu Sciences Inc. generated $0 in revenue, $0 in net income, and $0 in free cash flow against $7.7M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.
✓ Pre-computed one-to-many AI Quant brief
🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
EXT / AFTER-HRS: $2.82 (-0.50%)🧬 Disciplined Float (-0.40% YoY Shares)⚙️ Cash Engine: 10/20 (D) • 0.1% FCF Margin
Verify 90D Bucket Audit →📊 Historical Track Record: Scores of 56/100 (D+) historically posted market-perform odds over rolling 90-day windows (-0.4% avg 90D alpha vs SPY • 51.8% hit rate — wait for RQD ≥ 70 breakout).
Audit Bucket Track Record →RQD QUANT TACHOMETERSELL / AVOID • D+
JEV AI Jury Split (Battleground)
Cash
SEC
Whale
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
5-PILLAR SNOWFLAKE RADARRw D · Rk B-
Each axis scored 0–20
12M PRICE TARGET CONE-1.1% Base Target
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for CNXU)Realized 20D OHLCV Swing Band: ±12.5%
Deterministic 5-Pillar Attribution (56/100 Composite)
🔍 WHY CNXU SCORES 56/100 (D+) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: Macro Regime Fit+15/20 pts (27% of score)
FRED Regime × Technicals: 2% of 52W Range • RSI-14 at 33.9 (NEUTRAL RANGE)
▲ #2 Bullish Driver: SEC 10-K Forensic Risk+13/20 pts (23% of score)
Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 7/9
▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution9/20 pts (-11 pt drag)
Disciplined Float (-0.40% YoY Shares) & executive Form 4 sales trim 11 pts from alignment
📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)Grade C+$3.89-21.3% Next Q
64
Q2 (-2Q)Grade C$3.06+1.3% Next Q
61
Q3 (-1Q)Grade C$3.10-8.7% Next Q
59
CurrentGrade D+$2.83-0.4% Hist 90D α
56
Trajectory: C+ (64) → D+ (56)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)GIDEON ASHMERE // FORENSIC SHORT & KILL-SWITCH DOSSIER
⚔️ Adversarial Opposing Case: Why the CNXU Bull Thesis Could Fail
Even with a 56/100 (D+) score, CNXU faces multiple-compression risk if current valuation multiples re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.
⚠️ Forensic Kill-Switch #1
Company executives have done more routine share selling than personal cash buying lately.
⚠️ Forensic Kill-Switch #2
Dilution & Margin Drag: Disciplined Float (-0.40% YoY Shares) — any gross margin slip below 49.5% triggers an automatic RQD downgrade.
⚠️ Forensic Kill-Switch #3
Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($4.41) or 200D SMA ($7.93) invalidates the momentum regime and cuts Target Base ($2.80) toward Bear Floor ($2.18).
🎲 LIVE PREDICTION MARKET ODDS TIED TO $CNXU• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “CNXU Beats Next Quarter EPS Consensus (Jan 29, 2027) & Holds Above 200D SMA”
AUTOMATED RQD QUANT DESK MOVER BRIEFINGFull Market News Desk →
Why CNXU Stock slipped -1.74% Today — RQD Quant Desk Flash
Conexeu Sciences Inc. (CNXU) slipped -1.74% to $2.83, trading at 2% of its 52-week range ($2.43 – $18.79). Stretched risk/reward at current multiples (steady margins) under elevated 10-year interest-rate pressure.
- ▸Technical Tape: Trading at 2% of its 52-week range ($2.43 – $18.79) with RSI-14 at 33.9 (NEUTRAL RANGE).
- ▸Volatility Profile: Historical 20-day realized swing band of ±12.5% around $2.83 (no active unusual options sweep snapshot on file).
- ▸Fundamental Anchor: Roarable D+ (Sell) backed by 52% gross margin and $2.4M annual free cash flow.
Live CNXU Headlines & Catalysts
MARKET WIREReuters • 5h ago
Russia's FSB says minor detained over park attack threat after US tip-off - ReutersRussia's FSB says minor detained over park attack threat after US tip-off Reuters
MARKET WIREReuters • 5h ago
Oil slips more than 1% as talks continue on ending Iran war - ReutersOil slips more than 1% as talks continue on ending Iran war Reuters
MARKET WIREReuters • 6h ago
Nine people dead in Learjet crash in south Florida, officials say - ReutersNine people dead in Learjet crash in south Florida, officials say Reuters
MARKET WIREReuters • 8h ago
Iran's IRGC Navy says two tankers 'exploded' after hitting mines in Hormuz - ReutersIran's IRGC Navy says two tankers 'exploded' after hitting mines in Hormuz Reuters
MARKET WIRECNBC • 10h ago
Here are 3 big things we're watching in the stock market in the week aheadThe market could use a few victories in the days ahead, which will be filled with more earnings, an election, and jobs data.
MARKET WIRECNBC • 10h ago
Democratic Rep. Stevens endorses Rogers over El-Sayed in Michigan Senate electionHaley Stevens had lost the Democratic nomination for Senate in Michigan to Abdul El-Sayed earlier this year.
RISK WATCHReuters • 12h ago
Israeli strikes kill eight people in Gaza - medics say - ReutersIsraeli strikes kill eight people in Gaza - medics say Reuters
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk
Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring CNXU)
- ✓Walkthrough of CNXU's RQD Radar, SEC cash-conversion gap & downside invalidation levels
- ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
- ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
CNXU // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -78.35%⚡ TESTING RESISTANCE
2026-10-30O $2.85H $2.85L $2.43C $2.83VOL 517.3K
RES: $3.09SUP: $0.81SMA50: $4.41SMA200: $7.93
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK
CNXU Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Share Count & Dilution Monitor (#25)
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
Reverse-DCF Expectations Hurdle (#30)
8.0%/yr Implied 5Y Growth
vs. +6.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
Ellis Vennor Setup Ledger (#33)
No active Ellis Vennor swing setup published on CNXU today. View full Setup Ledger →
🦋 Documented & Second-Order Butterfly Connections
Open Graph →
No direct multi-tier Butterfly edges indexed yet for CNXU. Explore sector supply chains on /butterfly.
AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for CNXU today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK
📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (CNXU)
Health Care Rank #269 of 1016
⚔️ LAKE vs CNXU Full Matrix →
1. Head-to-Head Health Care Peer Comparison (CNXU vs. LAKE, NTRB, AGPU, APT)
Industry: Industrial Specialties (55 Tracked Issuers)Across 1016 tracked Health Care securities in the Roarable RQD universe, Conexeu Sciences Inc. (CNXU) ranks #269 by composite RQD confidence (56/100, grade D+) and #680 by equity capitalization ($85.8M). Within this direct 5-issuer industry benchmark cohort, APT leads on earnings valuation at 16.2x trailing P/E, while APT leads on capital efficiency and profitability with 6.7% ROIC and 38.1% gross margin. APT currently holds the highest overall quantitative score in the immediate peer group at 58/100 (D+) compared with CNXU at 56/100 (D+).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| CNXU
ACTIVE
Conexeu Sciences Inc. | D+ | 56/100 | — | — | — | -1.74% | $85.8M | Benchmark Subject |
| LAKE Lakeland Industries Inc. | D- | 38/100 | — | 32.9% | -9.5% | -1.11% | $88.2M | /lake-vs-cnxu → |
| NTRB Nutriband Inc. | D- | 40/100 | — | 27.8% | -35.0% | +3.75% | $80.7M | /ntrb-vs-cnxu → |
| AGPU Axe Compute Inc. | D- | 37/100 | — | — | -35.0% | -2.01% | $101.7M | /agpu-vs-cnxu → |
| APT Alpha Pro Tech Ltd. | D+ | 58/100 | 16.2x | 38.1% | 6.7% | +1.28% | $56.6M | /apt-vs-cnxu → |
2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2025–FY2025)
SEC EDGAR 10-K • FILED 2025-10-31 • CIK 0002066836In its most recent audited fiscal period (FY2025, filed 2025-10-31), Conexeu Sciences Inc. (CNXU) reported GAAP revenue of $0 , GAAP net income of $0, operating cash flow of $0, and free cash flow of $0 . On the balance sheet, CNXU closed FY2025 with $7.7M in total assets against $0 in total debt (Altman Z-Score: N/A, Piotroski F-Score: N/A).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2025-10-31 | $0 | $0 | — | — | $7.7M | — |
3. CNXU Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)
✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLEDIs CNXU stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-01, Conexeu Sciences Inc. (NASDAQ: CNXU) is rated D+ (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 56/100 at a spot price of $2.83 (-1.74% 1D, market cap $85.8M). Pillar breakdown: Fundamental Cash Engine 10/20, Institutional 13F & Options Flow 9/20, Executive Insider Alignment 13/20, FRED Macro Regime Fit 15/20, and SEC Balance-Sheet Forensics 9/20. Across 1016 tracked Health Care issuers, CNXU ranks #269 in composite RQD confidence.
How does CNXU compare to LAKE and NTRB in the Health Care sector?
Within the Health Care sector (Industrial Specialties), CNXU carries a Roarable D+ (56/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of —. By comparison, LAKE (Lakeland Industries Inc.) holds a D- grade (38/100 RQD, P/E N/A, ROIC -9.5%, cap $88.2M) and NTRB (Nutriband Inc.) posts a D- grade (40/100 RQD, P/E N/A, ROIC -35.0%, cap $80.7M). Among the 5-stock peer group, APT leads on earnings multiple (16.2x) while APT leads on capital efficiency (6.7% ROIC).
What are the biggest fundamental strengths and SEC risk factors for CNXU?
Per CNXU's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-10-31, CIK 0002066836), Conexeu Sciences Inc. generated $0 in revenue, $0 in net income, and $0 in free cash flow against $7.7M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.
Where is CNXU trading relative to its 50-day, 200-day, and 52-week technical levels?
CNXU last traded at $2.83 (-1.74% on volume of 413,953 shares), positioning the stock -35.83% below its 50-day simple moving average ($4.41) and -64.31% below its 200-day simple moving average ($7.93). Across its 52-week range of $2.43 to $18.79, CNXU sits at the 2.4% percentile with a 14-day RSI of 33.9 (NEUTRAL RANGE) and an implied next-earnings move of ±12.5% ($2.48 to $3.18).
CNXU Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhy is CNXU stock moving today?
Why CNXU Stock slipped -1.74% Today — RQD Quant Desk Flash. Stretched risk/reward at current multiples (steady margins) under elevated 10-year interest-rate pressure.